2024
Does cancer clinical trial enrollment for sexual and gender minority people differ from heterosexual, cisgender people?
Alpert A, Obedin-Maliver J, Gjelsvik A, Amanullah S, Shireman T, Blosnich J. Does cancer clinical trial enrollment for sexual and gender minority people differ from heterosexual, cisgender people? Contemporary Clinical Trials 2024, 146: 107695. PMID: 39303766, DOI: 10.1016/j.cct.2024.107695.Peer-Reviewed Original ResearchBehavioral Risk Factor Surveillance SurveyCancer clinical trial enrollmentClinical trial enrollmentTrial enrollmentRisk Factor Surveillance SurveySGM peopleNon-SGM individualsClinical trial participationCancer disparitiesSurveillance SurveyReport participationGender minority peopleTrial participantsSGM statusSGM individualsPartnership statusLogistic regressionCisgender peopleData collection methodsEnrollmentOncological treatmentOddsMinority peopleParticipantsSGM
2022
Improving Data-Driven Methods to Identify and Categorize Transgender Individuals by Gender in Insurance Claims Data
Hughto J, Hughes L, Yee K, Downing J, Ellison J, Alpert A, Jasuja G, Shireman T. Improving Data-Driven Methods to Identify and Categorize Transgender Individuals by Gender in Insurance Claims Data. LGBT Health 2022, 9: 254-263. PMID: 35290746, PMCID: PMC9150133, DOI: 10.1089/lgbt.2021.0433.Peer-Reviewed Original ResearchConceptsTransgender peopleGender categoriesTransgender individualsSample of transgender individualsChronic health conditionsTransgender populationTransgender samplesSex-specific conditionsOdds of post-traumatic stress disorderDrug use disordersHealth conditionsHealth disparitiesGender categorizationGenderCensus regionPeopleUse disorderTransgenderInsuranceAlcohol use disorderPost-traumatic stress disorderCensusIndividualsAtherosclerotic cardiovascular disordersLogistic regression